CN Stock MarketDetailed Quotes

300760 Shenzhen Mindray Bio-Medical Electronics

Watchlist
  • 299.77
  • -4.91-1.61%
Market Closed Jun 7 15:00 CST
363.45BMarket Cap29.86P/E (TTM)

Shenzhen Mindray Bio-Medical Electronics Key Stats

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Assets
Current assets
Money funds
-11.34%21.19B
-18.97%18.79B
27.39%19.67B
67.70%20.2B
60.46%23.91B
50.94%23.19B
20.09%15.44B
-22.97%12.05B
-10.51%14.9B
-3.17%15.36B
Notes receivable and accounts receivable
37.86%3.7B
23.90%3.3B
18.27%3.67B
15.17%3.71B
17.34%2.68B
48.62%2.66B
50.60%3.1B
67.46%3.22B
31.30%2.29B
16.32%1.79B
-Notes receivable
1,922.41%48.21M
-18.59%1.7M
-14.18%51.12M
-98.32%1.42M
-96.84%2.38M
-98.41%2.09M
-55.30%59.56M
62.18%84.28M
18,758.85%75.44M
37.08%131.7M
-Accounts receivable
36.18%3.65B
23.94%3.3B
18.91%3.62B
18.22%3.71B
21.23%2.68B
60.29%2.66B
57.91%3.05B
67.61%3.13B
26.99%2.21B
14.94%1.66B
Other receivables (including interest and dividends)
139.03%279.84M
30.84%195.1M
5.49%187.22M
18.00%186.39M
-20.47%117.07M
18.31%149.11M
-56.14%177.47M
-58.31%157.95M
-59.97%147.2M
-57.25%126.04M
-Other receivable
----
----
----
18.00%186.39M
----
18.31%149.11M
----
61.41%157.95M
----
124.98%126.04M
Advance payment
-27.24%251.34M
-7.48%267.79M
2.77%312.74M
16.35%321.78M
42.77%345.43M
21.68%289.43M
32.17%304.31M
46.27%276.56M
23.89%241.96M
18.59%237.87M
Inventories
-18.71%3.96B
-1.15%3.98B
-3.01%4.03B
12.25%4.43B
25.28%4.87B
12.89%4.02B
25.77%4.15B
17.07%3.94B
0.48%3.89B
0.70%3.57B
Non-current assets due within one year
25.86%40.69M
30.82%41.63M
27.20%38.63M
27.69%36.43M
22.60%32.33M
20.67%31.82M
19.61%30.37M
15.04%28.53M
10.33%26.37M
10.20%26.37M
Other current assets
-6.83%325.22M
16.67%308.07M
48.77%356.07M
77.72%333.12M
101.99%349.08M
21.13%264.06M
90.67%239.34M
39.50%187.44M
-26.97%172.82M
34.11%217.99M
Total current assets
-7.91%29.75B
-12.19%26.88B
20.53%28.26B
47.10%29.21B
49.01%32.3B
43.45%30.61B
23.37%23.45B
-8.30%19.86B
-6.08%21.68B
-1.35%21.33B
Non Current assets
Other equity investment
1,224.82%133.29M
--142.82M
--164.37M
--165.27M
--10.06M
----
----
----
----
----
Other non-current financial assets
--1.4B
--1.27B
--1.25B
--1.11B
----
----
----
----
----
----
Investment real estate
-4.39%41.01M
-4.35%41.49M
-4.30%41.96M
-4.25%42.43M
-4.21%42.9M
-4.17%43.37M
15.93%43.84M
15.89%44.31M
-24.45%44.78M
-26.08%45.26M
Long-term equity investment
-1.85%63.46M
9.48%66.56M
8.93%67.09M
8.00%65.1M
4.83%64.66M
130.69%60.8M
162.61%61.6M
150.99%60.28M
160.85%61.68M
3.18%26.36M
Long term receivable account
-52.46%8.4M
-56.72%10.94M
-64.18%13.95M
-69.69%14.14M
-45.66%17.67M
-26.81%25.28M
21.34%38.94M
143.23%46.66M
1,549.74%32.52M
940.54%34.55M
Fixed assets
----
----
----
25.77%4.81B
----
12.97%4.26B
----
13.33%3.82B
----
17.90%3.77B
Constru in process
----
----
----
27.06%1.8B
----
60.05%1.8B
----
24.28%1.42B
----
21.13%1.13B
Intangible assets
13.38%2.22B
12.56%2.22B
6.72%2.03B
6.55%1.98B
2.62%1.96B
-4.10%1.98B
-7.01%1.91B
71.59%1.86B
71.84%1.91B
80.01%2.06B
Development expenditure
2.34%324.43M
15.31%342.35M
33.27%294.77M
65.25%353.75M
77.49%317.01M
111.98%296.9M
-20.90%221.17M
-22.99%214.07M
-19.69%178.6M
-19.69%140.06M
Goodwill
12.66%4.98B
14.95%5.06B
6.19%4.51B
10.76%4.64B
6.26%4.42B
4.38%4.4B
-2.47%4.24B
244.95%4.19B
237.26%4.16B
244.48%4.22B
Long deferred expense
-13.80%67.68M
-9.29%74.88M
-12.71%76.6M
-20.75%72.1M
-2.56%78.51M
-1.93%82.55M
-0.56%87.75M
201.17%90.98M
147.72%80.57M
182.92%84.17M
Deferred tax assets
65.33%1.18B
73.87%1.31B
26.14%827.43M
26.95%775.12M
50.38%714.01M
26.60%755.08M
35.02%655.95M
37.36%610.57M
12.46%474.79M
18.84%596.43M
Usufruct assets
14.24%262.3M
19.71%270.37M
4.11%248.45M
-0.72%230.33M
2.58%229.6M
-3.17%225.85M
7.46%238.64M
8.17%232.01M
24.27%223.82M
23.07%233.24M
Other non current assets
2.88%2.28B
4.01%2.29B
-6.90%4.88B
-63.17%2.28B
-50.64%2.22B
-50.21%2.21B
17.81%5.24B
41.01%6.2B
2.04%4.49B
1.15%4.43B
Total non current assets
29.69%21.09B
30.52%21.06B
19.34%21.73B
-2.39%18.33B
-2.41%16.26B
-3.75%16.14B
9.57%18.21B
53.28%18.78B
39.29%16.66B
41.33%16.77B
Total assets
4.68%50.83B
2.56%47.94B
20.01%49.99B
23.05%47.54B
26.66%48.56B
22.68%46.75B
16.93%41.66B
13.96%38.64B
9.41%38.34B
13.77%38.1B
Liabilities
Current liabilities
Short term loan
--4.91M
--7.75M
----
----
----
----
----
----
----
----
Notes payable and accounts payable
-2.78%2.83B
17.45%2.69B
-6.12%2.57B
9.34%3B
16.67%2.91B
0.42%2.29B
50.43%2.74B
60.56%2.75B
24.17%2.5B
52.12%2.28B
-Accounts payable
-2.78%2.83B
17.45%2.69B
-6.12%2.57B
9.34%3B
16.67%2.91B
0.42%2.29B
50.43%2.74B
60.56%2.75B
24.17%2.5B
52.12%2.28B
Contract liabilities
-47.05%2.06B
-52.37%1.97B
11.68%1.89B
24.21%2.5B
78.66%3.89B
72.03%4.14B
-14.91%1.69B
-12.18%2.01B
-32.89%2.18B
-26.88%2.41B
Advance receipts
2,129.97%3.88M
163.73%793.44K
300.71%1.59M
-92.24%15.64K
-54.46%173.8K
29.80%300.85K
--396.66K
--201.54K
--381.67K
--231.79K
Salaries payable
28.79%2.99B
4.83%2.27B
7.78%2.66B
5.64%2.54B
4.56%2.32B
22.09%2.16B
21.38%2.47B
34.42%2.4B
37.97%2.22B
16.71%1.77B
Taxs payable
180.25%824.76M
13.92%653.24M
48.06%852.97M
5.38%748.38M
-14.51%294.3M
21.06%573.4M
15.88%576.09M
74.99%710.16M
43.15%344.25M
36.43%473.65M
Other payable (including interest and dividends)
18.48%1.86B
7.35%2.04B
10.25%1.67B
13.74%1.71B
34.48%1.57B
45.25%1.9B
28.88%1.51B
19.00%1.51B
0.06%1.17B
5.69%1.31B
-Other payable
----
----
----
13.74%1.71B
----
45.25%1.9B
----
19.00%1.51B
----
5.69%1.31B
Non current liabilities due within one year
2.75%101.02M
7.73%104.73M
1.86%99.73M
10.78%100.93M
15.65%98.32M
14.26%97.22M
29.53%97.91M
35.92%91.11M
29.53%85.02M
35.91%85.08M
Other current liabilities
-24.91%390.16M
-39.44%364.52M
12.36%385.2M
33.38%413.64M
64.14%519.57M
100.15%601.87M
17.12%342.82M
4.70%310.12M
-7.47%316.54M
-11.58%300.71M
Total current liabilities
-4.66%11.07B
-14.16%10.1B
7.42%10.13B
12.65%11.01B
31.78%11.61B
36.40%11.77B
19.57%9.43B
24.90%9.78B
1.48%8.81B
3.98%8.63B
Current liabilities
Long term loan
--973.9K
--1.38M
----
----
----
----
----
----
----
----
Long term salaries pay
22.96%1.8B
36.22%2.94B
79.13%2.15B
133.94%2.14B
83.84%1.46B
19.26%2.16B
-0.86%1.2B
-2.36%914.27M
-1.96%794.54M
30.41%1.81B
Estimate liabilities
104.99%501.95M
121.01%512.62M
23.79%274.28M
27.67%269.58M
27.07%244.86M
24.19%231.94M
15.96%221.57M
15.16%211.15M
10.76%192.7M
29.04%186.77M
Deferred tax liabilities
-2.95%170.62M
-8.06%168.36M
-8.11%166.2M
-5.25%177.35M
-7.46%175.81M
-8.63%183.13M
-21.54%180.87M
340.25%187.17M
323.63%189.98M
329.90%200.44M
Long term deferred income
34.23%116.72M
17.61%109.31M
20.17%100.01M
21.67%100.44M
-16.10%86.95M
-11.56%92.94M
-5.72%83.22M
-46.27%82.55M
-35.24%103.64M
-32.97%105.09M
Lease liabilities
24.27%176.1M
29.98%181.07M
8.12%161.29M
-4.68%141.53M
-1.31%141.7M
-8.44%139.31M
-0.17%149.18M
-0.91%148.47M
29.16%143.58M
24.74%152.15M
Other non current liabilities
245.58%568.51M
241.78%575.37M
11.35%189.43M
83.59%196.93M
227.67%164.51M
238.57%168.35M
240.72%170.11M
148.40%107.27M
16.82%50.2M
17.28%49.72M
Total non current liabilities
46.45%3.33B
50.90%4.49B
51.65%3.04B
83.22%3.02B
54.24%2.27B
18.77%2.98B
4.45%2B
9.41%1.65B
9.77%1.47B
31.77%2.51B
Total liabilities
3.71%14.4B
-1.03%14.59B
15.17%13.17B
22.84%14.04B
35.00%13.89B
32.43%14.75B
16.61%11.44B
22.39%11.43B
2.59%10.29B
9.16%11.13B
Shareholders equity
Paid-in capital
0.00%1.21B
0.00%1.21B
0.00%1.21B
0.00%1.21B
0.00%1.21B
-0.27%1.21B
-0.27%1.21B
-0.27%1.21B
-0.27%1.21B
0.00%1.22B
Capital reserve funds
-6.24%7.13B
-5.57%7.09B
0.44%7.44B
1.16%7.39B
5.44%7.6B
-7.90%7.51B
-9.11%7.41B
-10.35%7.31B
-11.54%7.21B
0.00%8.15B
Surplus reserve funds
0.00%607.85M
0.00%607.85M
0.00%607.85M
0.00%607.85M
0.00%607.85M
0.00%607.85M
0.00%607.85M
0.00%607.85M
0.00%607.85M
0.00%607.85M
Retained profit
5.73%27.84B
3.87%24.68B
26.44%28.14B
27.29%24.75B
28.50%26.33B
29.23%23.76B
30.55%22.26B
31.99%19.44B
35.35%20.49B
36.97%18.39B
Less:Treasury stock
-33.67%663.28M
-33.67%663.28M
-32.87%671.26M
-32.87%671.26M
0.00%999.99M
0.00%999.99M
0.00%999.99M
--999.99M
--999.99M
--999.99M
Other composite income
145.54%47.33M
244.19%157.27M
131.61%90.05M
156.33%213.1M
78.84%-103.93M
73.38%-109.07M
-27.69%-284.87M
-151.31%-378.32M
-327.86%-491.26M
-234.27%-409.74M
Shareholders equity without minority interests
4.39%36.17B
3.45%33.09B
21.92%36.82B
23.21%33.5B
23.62%34.65B
18.65%31.98B
17.06%30.2B
10.74%27.19B
12.13%28.03B
15.79%26.95B
Minority interests
1,213.37%256.22M
1,325.33%260.65M
----
----
13.80%19.51M
19.97%18.29M
19.75%18.2M
25.72%17.38M
29.42%17.14M
19.55%15.24M
Total shareholder equity
5.07%36.43B
4.21%33.35B
21.85%36.82B
23.13%33.5B
23.61%34.67B
18.66%32B
17.06%30.22B
10.75%27.21B
12.14%28.05B
15.79%26.97B
Total liabilityies and equity
4.68%50.83B
2.56%47.94B
20.01%49.99B
23.05%47.54B
26.66%48.56B
22.68%46.75B
16.93%41.66B
13.96%38.64B
9.41%38.34B
13.77%38.1B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)
--
--
--
PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)
--
--
--
PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Assets
Current assets
Money funds -11.34%21.19B-18.97%18.79B27.39%19.67B67.70%20.2B60.46%23.91B50.94%23.19B20.09%15.44B-22.97%12.05B-10.51%14.9B-3.17%15.36B
Notes receivable and accounts receivable 37.86%3.7B23.90%3.3B18.27%3.67B15.17%3.71B17.34%2.68B48.62%2.66B50.60%3.1B67.46%3.22B31.30%2.29B16.32%1.79B
-Notes receivable 1,922.41%48.21M-18.59%1.7M-14.18%51.12M-98.32%1.42M-96.84%2.38M-98.41%2.09M-55.30%59.56M62.18%84.28M18,758.85%75.44M37.08%131.7M
-Accounts receivable 36.18%3.65B23.94%3.3B18.91%3.62B18.22%3.71B21.23%2.68B60.29%2.66B57.91%3.05B67.61%3.13B26.99%2.21B14.94%1.66B
Other receivables (including interest and dividends) 139.03%279.84M30.84%195.1M5.49%187.22M18.00%186.39M-20.47%117.07M18.31%149.11M-56.14%177.47M-58.31%157.95M-59.97%147.2M-57.25%126.04M
-Other receivable ------------18.00%186.39M----18.31%149.11M----61.41%157.95M----124.98%126.04M
Advance payment -27.24%251.34M-7.48%267.79M2.77%312.74M16.35%321.78M42.77%345.43M21.68%289.43M32.17%304.31M46.27%276.56M23.89%241.96M18.59%237.87M
Inventories -18.71%3.96B-1.15%3.98B-3.01%4.03B12.25%4.43B25.28%4.87B12.89%4.02B25.77%4.15B17.07%3.94B0.48%3.89B0.70%3.57B
Non-current assets due within one year 25.86%40.69M30.82%41.63M27.20%38.63M27.69%36.43M22.60%32.33M20.67%31.82M19.61%30.37M15.04%28.53M10.33%26.37M10.20%26.37M
Other current assets -6.83%325.22M16.67%308.07M48.77%356.07M77.72%333.12M101.99%349.08M21.13%264.06M90.67%239.34M39.50%187.44M-26.97%172.82M34.11%217.99M
Total current assets -7.91%29.75B-12.19%26.88B20.53%28.26B47.10%29.21B49.01%32.3B43.45%30.61B23.37%23.45B-8.30%19.86B-6.08%21.68B-1.35%21.33B
Non Current assets
Other equity investment 1,224.82%133.29M--142.82M--164.37M--165.27M--10.06M--------------------
Other non-current financial assets --1.4B--1.27B--1.25B--1.11B------------------------
Investment real estate -4.39%41.01M-4.35%41.49M-4.30%41.96M-4.25%42.43M-4.21%42.9M-4.17%43.37M15.93%43.84M15.89%44.31M-24.45%44.78M-26.08%45.26M
Long-term equity investment -1.85%63.46M9.48%66.56M8.93%67.09M8.00%65.1M4.83%64.66M130.69%60.8M162.61%61.6M150.99%60.28M160.85%61.68M3.18%26.36M
Long term receivable account -52.46%8.4M-56.72%10.94M-64.18%13.95M-69.69%14.14M-45.66%17.67M-26.81%25.28M21.34%38.94M143.23%46.66M1,549.74%32.52M940.54%34.55M
Fixed assets ------------25.77%4.81B----12.97%4.26B----13.33%3.82B----17.90%3.77B
Constru in process ------------27.06%1.8B----60.05%1.8B----24.28%1.42B----21.13%1.13B
Intangible assets 13.38%2.22B12.56%2.22B6.72%2.03B6.55%1.98B2.62%1.96B-4.10%1.98B-7.01%1.91B71.59%1.86B71.84%1.91B80.01%2.06B
Development expenditure 2.34%324.43M15.31%342.35M33.27%294.77M65.25%353.75M77.49%317.01M111.98%296.9M-20.90%221.17M-22.99%214.07M-19.69%178.6M-19.69%140.06M
Goodwill 12.66%4.98B14.95%5.06B6.19%4.51B10.76%4.64B6.26%4.42B4.38%4.4B-2.47%4.24B244.95%4.19B237.26%4.16B244.48%4.22B
Long deferred expense -13.80%67.68M-9.29%74.88M-12.71%76.6M-20.75%72.1M-2.56%78.51M-1.93%82.55M-0.56%87.75M201.17%90.98M147.72%80.57M182.92%84.17M
Deferred tax assets 65.33%1.18B73.87%1.31B26.14%827.43M26.95%775.12M50.38%714.01M26.60%755.08M35.02%655.95M37.36%610.57M12.46%474.79M18.84%596.43M
Usufruct assets 14.24%262.3M19.71%270.37M4.11%248.45M-0.72%230.33M2.58%229.6M-3.17%225.85M7.46%238.64M8.17%232.01M24.27%223.82M23.07%233.24M
Other non current assets 2.88%2.28B4.01%2.29B-6.90%4.88B-63.17%2.28B-50.64%2.22B-50.21%2.21B17.81%5.24B41.01%6.2B2.04%4.49B1.15%4.43B
Total non current assets 29.69%21.09B30.52%21.06B19.34%21.73B-2.39%18.33B-2.41%16.26B-3.75%16.14B9.57%18.21B53.28%18.78B39.29%16.66B41.33%16.77B
Total assets 4.68%50.83B2.56%47.94B20.01%49.99B23.05%47.54B26.66%48.56B22.68%46.75B16.93%41.66B13.96%38.64B9.41%38.34B13.77%38.1B
Liabilities
Current liabilities
Short term loan --4.91M--7.75M--------------------------------
Notes payable and accounts payable -2.78%2.83B17.45%2.69B-6.12%2.57B9.34%3B16.67%2.91B0.42%2.29B50.43%2.74B60.56%2.75B24.17%2.5B52.12%2.28B
-Accounts payable -2.78%2.83B17.45%2.69B-6.12%2.57B9.34%3B16.67%2.91B0.42%2.29B50.43%2.74B60.56%2.75B24.17%2.5B52.12%2.28B
Contract liabilities -47.05%2.06B-52.37%1.97B11.68%1.89B24.21%2.5B78.66%3.89B72.03%4.14B-14.91%1.69B-12.18%2.01B-32.89%2.18B-26.88%2.41B
Advance receipts 2,129.97%3.88M163.73%793.44K300.71%1.59M-92.24%15.64K-54.46%173.8K29.80%300.85K--396.66K--201.54K--381.67K--231.79K
Salaries payable 28.79%2.99B4.83%2.27B7.78%2.66B5.64%2.54B4.56%2.32B22.09%2.16B21.38%2.47B34.42%2.4B37.97%2.22B16.71%1.77B
Taxs payable 180.25%824.76M13.92%653.24M48.06%852.97M5.38%748.38M-14.51%294.3M21.06%573.4M15.88%576.09M74.99%710.16M43.15%344.25M36.43%473.65M
Other payable (including interest and dividends) 18.48%1.86B7.35%2.04B10.25%1.67B13.74%1.71B34.48%1.57B45.25%1.9B28.88%1.51B19.00%1.51B0.06%1.17B5.69%1.31B
-Other payable ------------13.74%1.71B----45.25%1.9B----19.00%1.51B----5.69%1.31B
Non current liabilities due within one year 2.75%101.02M7.73%104.73M1.86%99.73M10.78%100.93M15.65%98.32M14.26%97.22M29.53%97.91M35.92%91.11M29.53%85.02M35.91%85.08M
Other current liabilities -24.91%390.16M-39.44%364.52M12.36%385.2M33.38%413.64M64.14%519.57M100.15%601.87M17.12%342.82M4.70%310.12M-7.47%316.54M-11.58%300.71M
Total current liabilities -4.66%11.07B-14.16%10.1B7.42%10.13B12.65%11.01B31.78%11.61B36.40%11.77B19.57%9.43B24.90%9.78B1.48%8.81B3.98%8.63B
Current liabilities
Long term loan --973.9K--1.38M--------------------------------
Long term salaries pay 22.96%1.8B36.22%2.94B79.13%2.15B133.94%2.14B83.84%1.46B19.26%2.16B-0.86%1.2B-2.36%914.27M-1.96%794.54M30.41%1.81B
Estimate liabilities 104.99%501.95M121.01%512.62M23.79%274.28M27.67%269.58M27.07%244.86M24.19%231.94M15.96%221.57M15.16%211.15M10.76%192.7M29.04%186.77M
Deferred tax liabilities -2.95%170.62M-8.06%168.36M-8.11%166.2M-5.25%177.35M-7.46%175.81M-8.63%183.13M-21.54%180.87M340.25%187.17M323.63%189.98M329.90%200.44M
Long term deferred income 34.23%116.72M17.61%109.31M20.17%100.01M21.67%100.44M-16.10%86.95M-11.56%92.94M-5.72%83.22M-46.27%82.55M-35.24%103.64M-32.97%105.09M
Lease liabilities 24.27%176.1M29.98%181.07M8.12%161.29M-4.68%141.53M-1.31%141.7M-8.44%139.31M-0.17%149.18M-0.91%148.47M29.16%143.58M24.74%152.15M
Other non current liabilities 245.58%568.51M241.78%575.37M11.35%189.43M83.59%196.93M227.67%164.51M238.57%168.35M240.72%170.11M148.40%107.27M16.82%50.2M17.28%49.72M
Total non current liabilities 46.45%3.33B50.90%4.49B51.65%3.04B83.22%3.02B54.24%2.27B18.77%2.98B4.45%2B9.41%1.65B9.77%1.47B31.77%2.51B
Total liabilities 3.71%14.4B-1.03%14.59B15.17%13.17B22.84%14.04B35.00%13.89B32.43%14.75B16.61%11.44B22.39%11.43B2.59%10.29B9.16%11.13B
Shareholders equity
Paid-in capital 0.00%1.21B0.00%1.21B0.00%1.21B0.00%1.21B0.00%1.21B-0.27%1.21B-0.27%1.21B-0.27%1.21B-0.27%1.21B0.00%1.22B
Capital reserve funds -6.24%7.13B-5.57%7.09B0.44%7.44B1.16%7.39B5.44%7.6B-7.90%7.51B-9.11%7.41B-10.35%7.31B-11.54%7.21B0.00%8.15B
Surplus reserve funds 0.00%607.85M0.00%607.85M0.00%607.85M0.00%607.85M0.00%607.85M0.00%607.85M0.00%607.85M0.00%607.85M0.00%607.85M0.00%607.85M
Retained profit 5.73%27.84B3.87%24.68B26.44%28.14B27.29%24.75B28.50%26.33B29.23%23.76B30.55%22.26B31.99%19.44B35.35%20.49B36.97%18.39B
Less:Treasury stock -33.67%663.28M-33.67%663.28M-32.87%671.26M-32.87%671.26M0.00%999.99M0.00%999.99M0.00%999.99M--999.99M--999.99M--999.99M
Other composite income 145.54%47.33M244.19%157.27M131.61%90.05M156.33%213.1M78.84%-103.93M73.38%-109.07M-27.69%-284.87M-151.31%-378.32M-327.86%-491.26M-234.27%-409.74M
Shareholders equity without minority interests 4.39%36.17B3.45%33.09B21.92%36.82B23.21%33.5B23.62%34.65B18.65%31.98B17.06%30.2B10.74%27.19B12.13%28.03B15.79%26.95B
Minority interests 1,213.37%256.22M1,325.33%260.65M--------13.80%19.51M19.97%18.29M19.75%18.2M25.72%17.38M29.42%17.14M19.55%15.24M
Total shareholder equity 5.07%36.43B4.21%33.35B21.85%36.82B23.13%33.5B23.61%34.67B18.66%32B17.06%30.22B10.75%27.21B12.14%28.05B15.79%26.97B
Total liabilityies and equity 4.68%50.83B2.56%47.94B20.01%49.99B23.05%47.54B26.66%48.56B22.68%46.75B16.93%41.66B13.96%38.64B9.41%38.34B13.77%38.1B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)------PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)------PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg